CIBRA Capital Ltd

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 2060725 LONDON, X0

Position in APLS

as of Mar 31, 2026 · filed Apr 24, 2026 Compact

Position Value

$2,011,500

New position

Shares Held

50,000

first reported quarter

Ownership

0.039%

of shares outstanding

% of Portfolio

0.98%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

CIBRA Capital Ltd holds $44,574,686 across 4 Biotechnology names. APLS ranks #4 (4.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	FOLD	AMICUS THERAPEUTICS, INC.	1,687,661	$24,403,578
2	ACLX	Arcellx, Inc.	88,623	$10,175,692
3	TERN	Terns Pharmaceuticals, Inc.	151,440	$7,983,916
4	APLS	Apellis Pharmaceuticals, Inc. This page	50,000	$2,011,500

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,011,500	50,000	—	Shares	Sole	2026-04-24
No filing history on record for this holder in this stock.